Biography

Federico Kalinec was born in Argentina and received his undergraduate degrees in physics and doctoral degree in biophysics from the University of Cordoba, Argentina. Following his graduate education, Dr. Kalinec completed a postdoctoral fellowship in Hearing Research and Neuroscience at the National Institute on Deafness and other Communication Disorders, National Institutes of Health (NIDCD-NIH).

Dr. Kalinec joined the House Ear Institute in 1996 as Head of the Section on Cell Structure and Function at the Department of Cell and Molecular Biology. He also holds positions as Associate Faculty Professor, Department of Otolaryngology and Clinical Assistant Professor, Department of Cell and Neurobiology at the University of Southern California, School of Medicine. Dr. Kalinec’s HEI research is focused primarily on auditory sensory cells – how they function normally as well as dysfunction in pathologies leading to hearing loss. Additionally, he and his research team are investigating the prevention of hearing loss induced in vivo and in vitro by ototoxic antibiotics (e.g. gentamicin) and antineoplastic agents (cisplatin). They are exploring the use of L-carnitine (LCAR), a safe micronutrient that plays a role in energy metabolism and detoxification, as a preventive measure against drug-induced hearing loss.

Dr. Kalinec is member of several professional organizations, and has published extensively in his field of expertise, most recently in Proceedings of the National Academy of Sciences, Biophysical Journal, Hearing Research, and Journal of Biological Chemistry. He has received several grants and awards, including the “Research Excellence Award” from the NIDCD-NIH.

...newsroom